Works in Diabetes, Obesity & Metabolism, 2017, Vol 19, Issue 3

Results: 23

Diabetes, Obesity and Metabolism.

Published in:: Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 307, doi. 10.1111/dom.12768
Publication type:: Article

Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 457, doi. 10.1111/dom.12831

By:

Ahn, Chang Ho;
Kim, Eun Ky;
Min, Se Hee;
Oh, Tae Jung;
Cho, Young Min

Publication type:

Article

Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 ( DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 394, doi. 10.1111/dom.12832

By:

Goldenberg, Ronald;
Gantz, Ira;
Andryuk, Paula J.;
O'Neill, Edward A.;
Kaufman, Keith D.;
Lai, Eseng;
Wang, Yin Na;
Suryawanshi, Shailaja;
Engel, Samuel S.

Publication type:

Article

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 401, doi. 10.1111/dom.12833

By:

Knapen, Lotte M.;
de Jong, Roy G. P. J.;
Driessen, Johanna H. M.;
Keulemans, Yolande C.;
van Erp, Nielka P.;
De Bruin, Marie L.;
Leufkens, Hubert G. M.;
Croes, Sander;
de Vries, Frank

Publication type:

Article

Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 412, doi. 10.1111/dom.12836

By:

Camastra, Stefania;
Astiarraga, Brenno;
Tura, Andrea;
Frascerra, Silvia;
Ciociaro, Demetrio;
Mari, Andrea;
Gastaldelli, Amalia;
Ferrannini, Ele

Publication type:

Article

Randomized, double-blind, phase III study to evaluate the efficacy and safety of once-daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 463, doi. 10.1111/dom.12837

By:

Kaku, Kohei;
Sumino, Shuuji;
Katou, Masafumi;
Nishiyama, Yuya;
Kinugawa, Yoshinobu

Publication type:

Article

Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 320, doi. 10.1111/dom.12820

By:

van Munster, Sanne N.;
van der Graaf, Yolanda;
de Valk, Harold W.;
Visseren, Frank L. J.;
Westerink, Jan

Publication type:

Article

Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 329, doi. 10.1111/dom.12821

By:

Bain, Steve;
Druyts, Eric;
Balijepalli, Chakrapani;
Baxter, Carl A.;
Currie, Craig J.;
Das, Romita;
Donnelly, Richard;
Khunti, Kamlesh;
Langerman, Haya;
Leigh, Paul;
Siliman, Gaye;
Thorlund, Kristian;
Toor, Kabirraaj;
Vora, Jiten;
Mills, Edward J.

Publication type:

Article

Gut feelings about diabetes and GLP-1 receptor agonists: lessons to be learnt from studies in functional gastrointestinal disorders.

Published in:

2017

By:

Rayner, Christopher K.;
Jones, Karen L.;
Wu, Tongzhi;
Horowitz, Michael

Publication type:

Editorial

Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 452, doi. 10.1111/dom.12823

By:

Mokhlesi, Babak;
Grimaldi, Daniela;
Beccuti, Guglielmo;
Van Cauter, Eve

Publication type:

Article

Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 336, doi. 10.1111/dom.12824

By:

Bettge, Karolin;
Kahle, Melanie;
Abd El Aziz, Mirna S.;
Meier, Juris J.;
Nauck, Michael A.

Publication type:

Article

Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 348, doi. 10.1111/dom.12825

By:

Li, Dandan;
Wang, Tiansheng;
Shen, Su;
Fang, Zhenwei;
Dong, Yue;
Tang, Huilin

Publication type:

Article

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 356, doi. 10.1111/dom.12826

By:

Preiss, David;
Dawed, Adem;
Welsh, Paul;
Heggie, Alison;
Jones, Angus G.;
Dekker, Jacqueline;
Koivula, Robert;
Hansen, Tue H.;
Stewart, Caitlin;
Holman, Rury R.;
Franks, Paul W.;
Walker, Mark;
Pearson, Ewan R.;
Sattar, Naveed

Publication type:

Article

Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 364, doi. 10.1111/dom.12827

By:

Gholap, Nitin N.;
Achana, Felix A.;
Davies, Melanie J.;
Ray, Kausik K.;
Gray, Laura;
Khunti, Kamlesh

Publication type:

Article

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 375, doi. 10.1111/dom.12828

By:

Wei, Wenhui;
Buysman, Erin;
Grabner, Michael;
Xie, Lin;
Brekke, Lee;
Ke, Xuehua;
Chu, James W.;
Levin, Philip A.

Publication type:

Article

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829

By:

Neal, Bruce;
Perkovic, Vlado;
Matthews, David R.;
Mahaffey, Kenneth W.;
Fulcher, Greg;
Meininger, Gary;
Erondu, Ngozi;
Desai, Mehul;
Shaw, Wayne;
Vercruysse, Frank;
Yee, Jacqueline;
Deng, Hsiaowei;
de Zeeuw, Dick

Publication type:

Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 468, doi. 10.1111/dom.12895

By:

Idris, Iskandar

Publication type:

Article

Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 421, doi. 10.1111/dom.12843

By:

Driessen, Johanna H. M.;
van den Bergh, Joop P. W.;
van Onzenoort, Hein A. W.;
Henry, Ronald M. A.;
Leufkens, Hubert G. M.;
de Vries, Frank

Publication type:

Article

Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 436, doi. 10.1111/dom.12816

By:

Tuttle, Katherine R.;
McKinney, T. Dwight;
Davidson, Jaime A.;
Anglin, Greg;
Harper, Kristine D.;
Botros, Fady T.

Publication type:

Article

Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 442, doi. 10.1111/dom.12817

By:

Yabe, Daisuke;
Eto, Takashi;
Shiramoto, Masanari;
Irie, Shin;
Murotani, Kenta;
Seino, Yusuke;
Kuwata, Hitoshi;
Kurose, Takeshi;
Seino, Susumu;
Ahrén, Bo;
Seino, Yutaka

Publication type:

Article

Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 313, doi. 10.1111/dom.12818

By:

Mitchell, Patricia L.;
Nachbar, Renato;
Lachance, Dominic;
St‐Pierre, Philippe;
Trottier, Jocelyn;
Barbier, Olivier;
Marette, André

Publication type:

Article

Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 448, doi. 10.1111/dom.12819

By:

Laugier‐Robiolle, Stéphanie;
Vergès, Bruno;
Le Bras, Maëlle;
Gand, Elise;
Bouillet, Benjamin;
Saulnier, Pierre‐Jean;
Le May, Cédric;
Pichelin, Matthieu;
Maréchaud, Richard;
Petit, Jean‐Michel;
Hadjadj, Samy;
Cariou, Bertrand

Publication type:

Article

Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 429, doi. 10.1111/dom.12844

By:

Kozlovski, Plamen;
Fonseca, Marilia;
Mohan, Viswanathan;
Lukashevich, Valentina;
Odawara, Masato;
Paldánius, Päivi M.;
Kothny, Wolfgang

Publication type:

Article